Insurtech Israel

Kobi Bendelak, the founder and CEO, leads investment decisions. Bendelak brings operational experience from senior roles at Israeli insurance carriers prior to launching the firm in 2017. He is supported by a compact investment team that evaluates deal flow sourced through the accelerator and direct founder outreach. The firm has not publicly disclosed an independent investment committee or outside board structure for fund-level decisions.

The firm's accelerator acts as a proprietary origination channel, identifying and backing startups at the earliest stages before they reach broader venture markets. Insurtech Israel also sources deals through its corporate innovation partnerships with global carriers — including AXA and Generali — who surface operational pain points that seed new investment theses. Israel's density of cybersecurity and AI talent feeds a natural pipeline that the firm's sector-specific brand attracts.

Insurtech Israel operates as a hybrid platform encompassing three units: a venture fund that makes direct equity investments, an in-house accelerator providing seed capital and operational support, and a corporate innovation lab that advises global insurance carriers. This structure generates both carried interest from fund returns and fee income from advisory engagements, creating a diversified revenue model atypical of pure-play venture capital firms.

The firm focuses on pre-seed through Series A investments, with the accelerator program primarily targeting pre-seed and seed-stage companies. Its venture fund reserves capital for follow-on investments through Series A. Insurtech Israel has not publicly indicated participation in growth-stage or late-stage rounds, positioning it as a dedicated early-stage specialist.

Core themes include AI-driven underwriting engines, parametric insurance platforms, claims automation, cyber-insurance risk modeling, and climate-risk analytics. The firm's September 2023 expansion into parametric and climate-risk verticals signaled a deliberate broadening beyond traditional property-and-casualty technology. Insurtech Israel has not disclosed explicit sector exclusions but has concentrated its portfolio in enterprise B2B models rather than direct-to-consumer insurtech.

Yes. Portfolio company Planck's $23 million round included co-investment from Team8 and Viola FinTech, indicating the firm regularly syndicates with larger Israeli and sector-focused venture investors. Insurtech Israel's early-stage positioning often makes it a first-check investor, with later rounds led by generalist or fintech-focused funds that the firm's corporate relationships help attract.

The corporate innovation lab functions as a paid advisory and scouting service for global insurers — including AXA, Generali, and Lloyd's market participants — helping them identify and pilot Israeli insurtech startups. These corporate relationships do not appear to be structured as limited partner commitments to the fund, maintaining operational independence. The firm's startups gain distribution pilots and enterprise feedback loops without exclusivity obligations to a single carrier.